Laurus Labs Ltd.
LAURUSLABS
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.
Shareholding Pattern
| On | Ind. Pro. | Fore. Pro. | FII/FPI | Mutual Funds | Banks | Insurance | Others | Non/Institution |
|---|---|---|---|---|---|---|---|---|
| 2024-09 | 27.18 | 0 | 26.08 | 8.25 | 0 | 4.06 | 0.74 | 33.69 |
| 2024-06 | 27.18 | 0 | 25.67 | 9.18 | 0 | 3.94 | 0.44 | 33.59 |
| 2024-03 | 27.19 | 0 | 25.98 | 6.68 | 0 | 4.75 | 0.34 | 35.07 |
| 2023-12 | 27.19 | 0 | 25.39 | 5.58 | 0.01 | 5.19 | 0.35 | 36.29 |
| 2023-09 | 27.2 | 0 | 24.03 | 5.29 | 0.01 | 5.41 | 0.30 | 37.76 |
| 2023-06 | 27.2 | 0 | 22.52 | 5.14 | 0.03 | 4.99 | 0.19 | 39.93 |
| 2023-03 | 27.2 | 0 | 22.42 | 5.4 | 0 | 4.15 | 0.19 | 40.64 |
| 2022-12 | 27.2 | 0 | 21.88 | 5.41 | 0 | 3.92 | 0.20 | 41.39 |
| 2022-09 | 27.27 | 0 | 22.65 | 5.5 | 0 | 3.48 | 0.36 | 40.74 |
Results
| On | Income from Inv. | Int. on Bank Bal. | Int. on Advances | Other Int. | Interest Earned | Interest Exp. | Net Interest Income | Expenditure | Operating Income | Other Income | Prov. & Contingencies | PBT | Tax | PAT | Net Profit | Consolidated Net Profit | Adjusted EPS(Rs.) | Gross NPA | Gross NPA(%) | Net NPA | Net NPA(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09 | 0 | 0 | 0 | 0 | 1223.7 | 52.61 | 1171.09 | 1045.37 | 182.93 | 4.6 | 0 | 22.81 | 5.09 | 17.72 | 17.72 | 19.84 | 0.37 | 0 | 0% | 0 | 0% |
| 2024-06 | 0 | 0 | 0 | 0 | 1194.91 | 49.19 | 1145.72 | 1023.71 | 173.71 | 2.51 | 0 | 18.46 | 6.25 | 12.21 | 12.21 | 12.51 | 0.23 | 0 | 0% | 0 | 0% |
| 2024-03 | 0 | 0 | 0 | 0 | 1439.67 | 50.5 | 1389.17 | 1198.18 | 260.02 | 18.53 | 0 | 107.27 | 31.95 | 75.32 | 75.32 | 75.61 | 1.40 | 0 | 0% | 0 | 0% |
| 2023-12 | 0 | 0 | 0 | 0 | 1194.92 | 50.82 | 1144.1 | 1013.5 | 183.85 | 2.43 | 0 | 34.62 | 9.45 | 25.17 | 25.17 | 23.14 | 0.43 | 0 | 0% | 0 | 0% |
| 2023-09 | 0 | 0 | 0 | 0 | 1224.45 | 42.39 | 1182.06 | 1036.58 | 189.65 | 1.78 | 0 | 53.89 | 14.57 | 39.32 | 39.32 | 36.95 | 0.69 | 0 | 0% | 0 | 0% |
| 2023-06 | 0 | 0 | 0 | 0 | 1181.79 | 39.19 | 1142.6 | 1015.07 | 170.32 | 3.6 | 0 | 40.58 | 12.18 | 28.4 | 28.4 | 24.85 | 0.46 | 0 | 0% | 0 | 0% |
| 2023-03 | 0 | 0 | 0 | 0 | 1380.9 | 53.1 | 1327.8 | 1095.36 | 287.25 | 1.71 | 0 | 147.14 | 39.9 | 107.24 | 107.24 | 102.98 | 1.91 | 0 | 0% | 0 | 0% |
| 2022-12 | 0 | 0 | 0 | 0 | 1544.82 | 42.71 | 1502.11 | 1141.25 | 405 | 1.43 | 0 | 277.85 | 74.79 | 203.06 | 203.06 | 203.04 | 3.77 | 0 | 0% | 0 | 0% |
| 2022-09 | 0 | 0 | 0 | 0 | 1575.89 | 40.11 | 1535.78 | 1126.98 | 450.02 | 1.11 | 0 | 328.07 | 94.27 | 233.8 | 233.8 | 232.81 | 4.33 | 0 | 0% | 0 | 0% |
| 2022-06 | 0 | 0 | 0 | 0 | 1538.94 | 29.25 | 1509.69 | 1084.77 | 455.92 | 1.75 | 0 | 355.88 | 103.34 | 252.54 | 252.54 | 251.28 | 4.68 | 0 | 0% | 0 | 0% |